The global market for Gemcitabine Hydrochloride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Gemcitabine hydrochloride is a new type of synthetic difluoronucleoside anti-metabolite anti-tumor drug

North American market for Gemcitabine Hydrochloride API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Gemcitabine Hydrochloride API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Gemcitabine Hydrochloride API include Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical, Shanghai Chuangnuo Pharmaceutical, Fu'an Pharmaceutical Group, Hubei Bantian Pharmaceutical, Shandong Anhong Pharmaceutical, Zhejiang Hisun Pharmaceutical, Jiangsu Zhengda Qingjiang Pharmaceutical, Lianyungang Jerry Pharmaceutical, Jiangsu Hansoh Pharmaceutical Group, Shandong Luoxin Pharmaceutical Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gemcitabine Hydrochloride API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gemcitabine Hydrochloride API.

The Gemcitabine Hydrochloride API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gemcitabine Hydrochloride API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gemcitabine Hydrochloride API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gemcitabine Hydrochloride API Market Report

Report Metric	Details
Report Name	Gemcitabine Hydrochloride API Market
by Type	0.99 0.98 Others
by Application	Pharmaceutical Research
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical, Shanghai Chuangnuo Pharmaceutical, Fu'an Pharmaceutical Group, Hubei Bantian Pharmaceutical, Shandong Anhong Pharmaceutical, Zhejiang Hisun Pharmaceutical, Jiangsu Zhengda Qingjiang Pharmaceutical, Lianyungang Jerry Pharmaceutical, Jiangsu Hansoh Pharmaceutical Group, Shandong Luoxin Pharmaceutical Group, Lianyungang Runzhong Pharmaceutical, Sanofi, Dr. Reddy's, LGC Limited, Navone Specialties
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gemcitabine Hydrochloride API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Gemcitabine Hydrochloride API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Gemcitabine Hydrochloride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gemcitabine Hydrochloride API Market report?

Ans: The main players in the Gemcitabine Hydrochloride API Market are Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical, Shanghai Chuangnuo Pharmaceutical, Fu'an Pharmaceutical Group, Hubei Bantian Pharmaceutical, Shandong Anhong Pharmaceutical, Zhejiang Hisun Pharmaceutical, Jiangsu Zhengda Qingjiang Pharmaceutical, Lianyungang Jerry Pharmaceutical, Jiangsu Hansoh Pharmaceutical Group, Shandong Luoxin Pharmaceutical Group, Lianyungang Runzhong Pharmaceutical, Sanofi, Dr. Reddy's, LGC Limited, Navone Specialties

What are the Application segmentation covered in the Gemcitabine Hydrochloride API Market report?

Ans: The Applications covered in the Gemcitabine Hydrochloride API Market report are Pharmaceutical, Research

What are the Type segmentation covered in the Gemcitabine Hydrochloride API Market report?

Ans: The Types covered in the Gemcitabine Hydrochloride API Market report are 0.99, 0.98, Others

1 Gemcitabine Hydrochloride API Market Overview

1.1 Product Definition

1.2 Gemcitabine Hydrochloride API by Type

1.2.1 Global Gemcitabine Hydrochloride API Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 0.99

1.2.3 0.98

1.2.4 Others

1.3 Gemcitabine Hydrochloride API by Application

1.3.1 Global Gemcitabine Hydrochloride API Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Pharmaceutical

1.3.3 Research

1.4 Global Market Growth Prospects

1.4.1 Global Gemcitabine Hydrochloride API Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Gemcitabine Hydrochloride API Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Gemcitabine Hydrochloride API Production Estimates and Forecasts (2020-2031)

1.4.4 Global Gemcitabine Hydrochloride API Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Gemcitabine Hydrochloride API Production Market Share by Manufacturers (2020-2025)

2.2 Global Gemcitabine Hydrochloride API Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Gemcitabine Hydrochloride API, Industry Ranking, 2023 VS 2024

2.4 Global Gemcitabine Hydrochloride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Gemcitabine Hydrochloride API Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Gemcitabine Hydrochloride API, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Gemcitabine Hydrochloride API, Product Offered and Application

2.8 Global Key Manufacturers of Gemcitabine Hydrochloride API, Date of Enter into This Industry

2.9 Gemcitabine Hydrochloride API Market Competitive Situation and Trends

2.9.1 Gemcitabine Hydrochloride API Market Concentration Rate

2.9.2 Global 5 and 10 Largest Gemcitabine Hydrochloride API Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Gemcitabine Hydrochloride API Production by Region

3.1 Global Gemcitabine Hydrochloride API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Gemcitabine Hydrochloride API Production Value by Region (2020-2031)

3.2.1 Global Gemcitabine Hydrochloride API Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Gemcitabine Hydrochloride API by Region (2026-2031)

3.3 Global Gemcitabine Hydrochloride API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Gemcitabine Hydrochloride API Production Volume by Region (2020-2031)

3.4.1 Global Gemcitabine Hydrochloride API Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Gemcitabine Hydrochloride API by Region (2026-2031)

3.5 Global Gemcitabine Hydrochloride API Market Price Analysis by Region (2020-2025)

3.6 Global Gemcitabine Hydrochloride API Production and Value, Year-over-Year Growth

3.6.1 North America Gemcitabine Hydrochloride API Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Gemcitabine Hydrochloride API Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Gemcitabine Hydrochloride API Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Gemcitabine Hydrochloride API Production Value Estimates and Forecasts (2020-2031)

4 Gemcitabine Hydrochloride API Consumption by Region

4.1 Global Gemcitabine Hydrochloride API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Gemcitabine Hydrochloride API Consumption by Region (2020-2031)

4.2.1 Global Gemcitabine Hydrochloride API Consumption by Region (2020-2025)

4.2.2 Global Gemcitabine Hydrochloride API Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Gemcitabine Hydrochloride API Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Gemcitabine Hydrochloride API Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Gemcitabine Hydrochloride API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Gemcitabine Hydrochloride API Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Gemcitabine Hydrochloride API Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Gemcitabine Hydrochloride API Production by Type (2020-2031)

5.1.1 Global Gemcitabine Hydrochloride API Production by Type (2020-2025)

5.1.2 Global Gemcitabine Hydrochloride API Production by Type (2026-2031)

5.1.3 Global Gemcitabine Hydrochloride API Production Market Share by Type (2020-2031)

5.2 Global Gemcitabine Hydrochloride API Production Value by Type (2020-2031)

5.2.1 Global Gemcitabine Hydrochloride API Production Value by Type (2020-2025)

5.2.2 Global Gemcitabine Hydrochloride API Production Value by Type (2026-2031)

5.2.3 Global Gemcitabine Hydrochloride API Production Value Market Share by Type (2020-2031)

5.3 Global Gemcitabine Hydrochloride API Price by Type (2020-2031)

6 Segment by Application

6.1 Global Gemcitabine Hydrochloride API Production by Application (2020-2031)

6.1.1 Global Gemcitabine Hydrochloride API Production by Application (2020-2025)

6.1.2 Global Gemcitabine Hydrochloride API Production by Application (2026-2031)

6.1.3 Global Gemcitabine Hydrochloride API Production Market Share by Application (2020-2031)

6.2 Global Gemcitabine Hydrochloride API Production Value by Application (2020-2031)

6.2.1 Global Gemcitabine Hydrochloride API Production Value by Application (2020-2025)

6.2.2 Global Gemcitabine Hydrochloride API Production Value by Application (2026-2031)

6.2.3 Global Gemcitabine Hydrochloride API Production Value Market Share by Application (2020-2031)

6.3 Global Gemcitabine Hydrochloride API Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical

7.1.1 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Company Information

7.1.2 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio

7.1.3 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Main Business and Markets Served

7.1.5 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Recent Developments/Updates

7.2 Shanghai Chuangnuo Pharmaceutical

7.2.1 Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Company Information

7.2.2 Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio

7.2.3 Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Shanghai Chuangnuo Pharmaceutical Main Business and Markets Served

7.2.5 Shanghai Chuangnuo Pharmaceutical Recent Developments/Updates

7.3 Fu'an Pharmaceutical Group

7.3.1 Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Company Information

7.3.2 Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Product Portfolio

7.3.3 Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Fu'an Pharmaceutical Group Main Business and Markets Served

7.3.5 Fu'an Pharmaceutical Group Recent Developments/Updates

7.4 Hubei Bantian Pharmaceutical

7.4.1 Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Company Information

7.4.2 Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio

7.4.3 Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Hubei Bantian Pharmaceutical Main Business and Markets Served

7.4.5 Hubei Bantian Pharmaceutical Recent Developments/Updates

7.5 Shandong Anhong Pharmaceutical

7.5.1 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Company Information

7.5.2 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio

7.5.3 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Shandong Anhong Pharmaceutical Main Business and Markets Served

7.5.5 Shandong Anhong Pharmaceutical Recent Developments/Updates

7.6 Zhejiang Hisun Pharmaceutical

7.6.1 Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Company Information

7.6.2 Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio

7.6.3 Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Zhejiang Hisun Pharmaceutical Main Business and Markets Served

7.6.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates

7.7 Jiangsu Zhengda Qingjiang Pharmaceutical

7.7.1 Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Company Information

7.7.2 Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio

7.7.3 Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Jiangsu Zhengda Qingjiang Pharmaceutical Main Business and Markets Served

7.7.5 Jiangsu Zhengda Qingjiang Pharmaceutical Recent Developments/Updates

7.8 Lianyungang Jerry Pharmaceutical

7.8.1 Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Company Information

7.8.2 Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio

7.8.3 Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Lianyungang Jerry Pharmaceutical Main Business and Markets Served

7.8.5 Lianyungang Jerry Pharmaceutical Recent Developments/Updates

7.9 Jiangsu Hansoh Pharmaceutical Group

7.9.1 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Company Information

7.9.2 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Product Portfolio

7.9.3 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Jiangsu Hansoh Pharmaceutical Group Main Business and Markets Served

7.9.5 Jiangsu Hansoh Pharmaceutical Group Recent Developments/Updates

7.10 Shandong Luoxin Pharmaceutical Group

7.10.1 Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Company Information

7.10.2 Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Product Portfolio

7.10.3 Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Shandong Luoxin Pharmaceutical Group Main Business and Markets Served

7.10.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates

7.11 Lianyungang Runzhong Pharmaceutical

7.11.1 Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Company Information

7.11.2 Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio

7.11.3 Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.11.4 Lianyungang Runzhong Pharmaceutical Main Business and Markets Served

7.11.5 Lianyungang Runzhong Pharmaceutical Recent Developments/Updates

7.12 Sanofi

7.12.1 Sanofi Gemcitabine Hydrochloride API Company Information

7.12.2 Sanofi Gemcitabine Hydrochloride API Product Portfolio

7.12.3 Sanofi Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.12.4 Sanofi Main Business and Markets Served

7.12.5 Sanofi Recent Developments/Updates

7.13 Dr. Reddy's

7.13.1 Dr. Reddy's Gemcitabine Hydrochloride API Company Information

7.13.2 Dr. Reddy's Gemcitabine Hydrochloride API Product Portfolio

7.13.3 Dr. Reddy's Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.13.4 Dr. Reddy's Main Business and Markets Served

7.13.5 Dr. Reddy's Recent Developments/Updates

7.14 LGC Limited

7.14.1 LGC Limited Gemcitabine Hydrochloride API Company Information

7.14.2 LGC Limited Gemcitabine Hydrochloride API Product Portfolio

7.14.3 LGC Limited Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.14.4 LGC Limited Main Business and Markets Served

7.14.5 LGC Limited Recent Developments/Updates

7.15 Navone Specialties

7.15.1 Navone Specialties Gemcitabine Hydrochloride API Company Information

7.15.2 Navone Specialties Gemcitabine Hydrochloride API Product Portfolio

7.15.3 Navone Specialties Gemcitabine Hydrochloride API Production, Value, Price and Gross Margin (2020-2025)

7.15.4 Navone Specialties Main Business and Markets Served

7.15.5 Navone Specialties Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Gemcitabine Hydrochloride API Industry Chain Analysis

8.2 Gemcitabine Hydrochloride API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Gemcitabine Hydrochloride API Production Mode & Process Analysis

8.4 Gemcitabine Hydrochloride API Sales and Marketing

8.4.1 Gemcitabine Hydrochloride API Sales Channels

8.4.2 Gemcitabine Hydrochloride API Distributors

8.5 Gemcitabine Hydrochloride API Customer Analysis

9 Gemcitabine Hydrochloride API Market Dynamics

9.1 Gemcitabine Hydrochloride API Industry Trends

9.2 Gemcitabine Hydrochloride API Market Drivers

9.3 Gemcitabine Hydrochloride API Market Challenges

9.4 Gemcitabine Hydrochloride API Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical

Shanghai Chuangnuo Pharmaceutical

Fu 'an Pharmaceutical Group

Shandong Anhong Pharmaceutical

Zhejiang Hisun Pharmaceutical

Jiangsu Zhengda Qingjiang Pharmaceutical

Shandong Luoxin Pharmaceutical Group

Lianyungang Runzhong Pharmaceutical

Sanofi

Dr. Reddy's

LGC

Hubei Bantian Pharmaceutical

Lianyungang Jerry Pharmaceutical

Navone Specialties

List of Tables

Table 1. Global Gemcitabine Hydrochloride API Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Gemcitabine Hydrochloride API Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Gemcitabine Hydrochloride API Production Capacity (Tons) by Manufacturers in 2024

Table 4. Global Gemcitabine Hydrochloride API Production by Manufacturers (2020-2025) & (Tons)

Table 5. Global Gemcitabine Hydrochloride API Production Market Share by Manufacturers (2020-2025)

Table 6. Global Gemcitabine Hydrochloride API Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Gemcitabine Hydrochloride API Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Gemcitabine Hydrochloride API, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Gemcitabine Hydrochloride API as of 2024)

Table 10. Global Market Gemcitabine Hydrochloride API Average Price by Manufacturers (US$/Ton) & (2020-2025)

Table 11. Global Key Manufacturers of Gemcitabine Hydrochloride API, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Gemcitabine Hydrochloride API, Product Offered and Application

Table 13. Global Key Manufacturers of Gemcitabine Hydrochloride API, Date of Enter into This Industry

Table 14. Global Gemcitabine Hydrochloride API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Gemcitabine Hydrochloride API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Gemcitabine Hydrochloride API Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Gemcitabine Hydrochloride API Production Value Market Share by Region (2020-2025)

Table 19. Global Gemcitabine Hydrochloride API Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Gemcitabine Hydrochloride API Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Gemcitabine Hydrochloride API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global Gemcitabine Hydrochloride API Production (Tons) by Region (2020-2025)

Table 23. Global Gemcitabine Hydrochloride API Production Market Share by Region (2020-2025)

Table 24. Global Gemcitabine Hydrochloride API Production (Tons) Forecast by Region (2026-2031)

Table 25. Global Gemcitabine Hydrochloride API Production Market Share Forecast by Region (2026-2031)

Table 26. Global Gemcitabine Hydrochloride API Market Average Price (US$/Ton) by Region (2020-2025)

Table 27. Global Gemcitabine Hydrochloride API Market Average Price (US$/Ton) by Region (2026-2031)

Table 28. Global Gemcitabine Hydrochloride API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 29. Global Gemcitabine Hydrochloride API Consumption by Region (2020-2025) & (Tons)

Table 30. Global Gemcitabine Hydrochloride API Consumption Market Share by Region (2020-2025)

Table 31. Global Gemcitabine Hydrochloride API Forecasted Consumption by Region (2026-2031) & (Tons)

Table 32. Global Gemcitabine Hydrochloride API Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 34. North America Gemcitabine Hydrochloride API Consumption by Country (2020-2025) & (Tons)

Table 35. North America Gemcitabine Hydrochloride API Consumption by Country (2026-2031) & (Tons)

Table 36. Europe Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 37. Europe Gemcitabine Hydrochloride API Consumption by Country (2020-2025) & (Tons)

Table 38. Europe Gemcitabine Hydrochloride API Consumption by Country (2026-2031) & (Tons)

Table 39. Asia Pacific Gemcitabine Hydrochloride API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 40. Asia Pacific Gemcitabine Hydrochloride API Consumption by Region (2020-2025) & (Tons)

Table 41. Asia Pacific Gemcitabine Hydrochloride API Consumption by Region (2026-2031) & (Tons)

Table 42. Latin America, Middle East & Africa Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 43. Latin America, Middle East & Africa Gemcitabine Hydrochloride API Consumption by Country (2020-2025) & (Tons)

Table 44. Latin America, Middle East & Africa Gemcitabine Hydrochloride API Consumption by Country (2026-2031) & (Tons)

Table 45. Global Gemcitabine Hydrochloride API Production (Tons) by Type (2020-2025)

Table 46. Global Gemcitabine Hydrochloride API Production (Tons) by Type (2026-2031)

Table 47. Global Gemcitabine Hydrochloride API Production Market Share by Type (2020-2025)

Table 48. Global Gemcitabine Hydrochloride API Production Market Share by Type (2026-2031)

Table 49. Global Gemcitabine Hydrochloride API Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Gemcitabine Hydrochloride API Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Gemcitabine Hydrochloride API Production Value Market Share by Type (2020-2025)

Table 52. Global Gemcitabine Hydrochloride API Production Value Market Share by Type (2026-2031)

Table 53. Global Gemcitabine Hydrochloride API Price (US$/Ton) by Type (2020-2025)

Table 54. Global Gemcitabine Hydrochloride API Price (US$/Ton) by Type (2026-2031)

Table 55. Global Gemcitabine Hydrochloride API Production (Tons) by Application (2020-2025)

Table 56. Global Gemcitabine Hydrochloride API Production (Tons) by Application (2026-2031)

Table 57. Global Gemcitabine Hydrochloride API Production Market Share by Application (2020-2025)

Table 58. Global Gemcitabine Hydrochloride API Production Market Share by Application (2026-2031)

Table 59. Global Gemcitabine Hydrochloride API Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Gemcitabine Hydrochloride API Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Gemcitabine Hydrochloride API Production Value Market Share by Application (2020-2025)

Table 62. Global Gemcitabine Hydrochloride API Production Value Market Share by Application (2026-2031)

Table 63. Global Gemcitabine Hydrochloride API Price (US$/Ton) by Application (2020-2025)

Table 64. Global Gemcitabine Hydrochloride API Price (US$/Ton) by Application (2026-2031)

Table 65. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Company Information

Table 66. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Specification and Application

Table 67. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 68. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Main Business and Markets Served

Table 69. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Recent Developments/Updates

Table 70. Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Company Information

Table 71. Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Specification and Application

Table 72. Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Shanghai Chuangnuo Pharmaceutical Main Business and Markets Served

Table 74. Shanghai Chuangnuo Pharmaceutical Recent Developments/Updates

Table 75. Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Company Information

Table 76. Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Specification and Application

Table 77. Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. Fu'an Pharmaceutical Group Main Business and Markets Served

Table 79. Fu'an Pharmaceutical Group Recent Developments/Updates

Table 80. Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Company Information

Table 81. Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Specification and Application

Table 82. Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Hubei Bantian Pharmaceutical Main Business and Markets Served

Table 84. Hubei Bantian Pharmaceutical Recent Developments/Updates

Table 85. Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Company Information

Table 86. Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Specification and Application

Table 87. Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Shandong Anhong Pharmaceutical Main Business and Markets Served

Table 89. Shandong Anhong Pharmaceutical Recent Developments/Updates

Table 90. Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Company Information

Table 91. Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Specification and Application

Table 92. Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Zhejiang Hisun Pharmaceutical Main Business and Markets Served

Table 94. Zhejiang Hisun Pharmaceutical Recent Developments/Updates

Table 95. Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Company Information

Table 96. Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Specification and Application

Table 97. Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Jiangsu Zhengda Qingjiang Pharmaceutical Main Business and Markets Served

Table 99. Jiangsu Zhengda Qingjiang Pharmaceutical Recent Developments/Updates

Table 100. Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Company Information

Table 101. Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Specification and Application

Table 102. Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. Lianyungang Jerry Pharmaceutical Main Business and Markets Served

Table 104. Lianyungang Jerry Pharmaceutical Recent Developments/Updates

Table 105. Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Company Information

Table 106. Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Specification and Application

Table 107. Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. Jiangsu Hansoh Pharmaceutical Group Main Business and Markets Served

Table 109. Jiangsu Hansoh Pharmaceutical Group Recent Developments/Updates

Table 110. Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Company Information

Table 111. Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Specification and Application

Table 112. Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. Shandong Luoxin Pharmaceutical Group Main Business and Markets Served

Table 114. Shandong Luoxin Pharmaceutical Group Recent Developments/Updates

Table 115. Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Company Information

Table 116. Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Specification and Application

Table 117. Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. Lianyungang Runzhong Pharmaceutical Main Business and Markets Served

Table 119. Lianyungang Runzhong Pharmaceutical Recent Developments/Updates

Table 120. Sanofi Gemcitabine Hydrochloride API Company Information

Table 121. Sanofi Gemcitabine Hydrochloride API Specification and Application

Table 122. Sanofi Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 123. Sanofi Main Business and Markets Served

Table 124. Sanofi Recent Developments/Updates

Table 125. Dr. Reddy's Gemcitabine Hydrochloride API Company Information

Table 126. Dr. Reddy's Gemcitabine Hydrochloride API Specification and Application

Table 127. Dr. Reddy's Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 128. Dr. Reddy's Main Business and Markets Served

Table 129. Dr. Reddy's Recent Developments/Updates

Table 130. LGC Limited Gemcitabine Hydrochloride API Company Information

Table 131. LGC Limited Gemcitabine Hydrochloride API Specification and Application

Table 132. LGC Limited Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 133. LGC Limited Main Business and Markets Served

Table 134. LGC Limited Recent Developments/Updates

Table 135. Navone Specialties Gemcitabine Hydrochloride API Company Information

Table 136. Navone Specialties Gemcitabine Hydrochloride API Specification and Application

Table 137. Navone Specialties Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 138. Navone Specialties Main Business and Markets Served

Table 139. Navone Specialties Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Gemcitabine Hydrochloride API Distributors List

Table 143. Gemcitabine Hydrochloride API Customers List

Table 144. Gemcitabine Hydrochloride API Market Trends

Table 145. Gemcitabine Hydrochloride API Market Drivers

Table 146. Gemcitabine Hydrochloride API Market Challenges

Table 147. Gemcitabine Hydrochloride API Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Gemcitabine Hydrochloride API

Figure 2. Global Gemcitabine Hydrochloride API Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Gemcitabine Hydrochloride API Market Share by Type: 2024 VS 2031

Figure 4. 0.99 Product Picture

Figure 5. 0.98 Product Picture

Figure 6. Others Product Picture

Figure 7. Global Gemcitabine Hydrochloride API Market Value by Application, (US$ Million) & (2020-2031)

Figure 8. Global Gemcitabine Hydrochloride API Market Share by Application: 2024 VS 2031

Figure 9. Pharmaceutical

Figure 10. Research

Figure 11. Global Gemcitabine Hydrochloride API Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Gemcitabine Hydrochloride API Production Value (US$ Million) & (2020-2031)

Figure 13. Global Gemcitabine Hydrochloride API Production Capacity (Tons) & (2020-2031)

Figure 14. Global Gemcitabine Hydrochloride API Production (Tons) & (2020-2031)

Figure 15. Global Gemcitabine Hydrochloride API Average Price (US$/Ton) & (2020-2031)

Figure 16. Gemcitabine Hydrochloride API Report Years Considered

Figure 17. Gemcitabine Hydrochloride API Production Share by Manufacturers in 2024

Figure 18. Global Gemcitabine Hydrochloride API Production Value Share by Manufacturers (2024)

Figure 19. Gemcitabine Hydrochloride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. The Global 5 and 10 Largest Players: Market Share by Gemcitabine Hydrochloride API Revenue in 2024

Figure 21. Global Gemcitabine Hydrochloride API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 22. Global Gemcitabine Hydrochloride API Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 23. Global Gemcitabine Hydrochloride API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 24. Global Gemcitabine Hydrochloride API Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 25. North America Gemcitabine Hydrochloride API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 26. Europe Gemcitabine Hydrochloride API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. China Gemcitabine Hydrochloride API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. Japan Gemcitabine Hydrochloride API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Global Gemcitabine Hydrochloride API Consumption by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 30. Global Gemcitabine Hydrochloride API Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 31. North America Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 32. North America Gemcitabine Hydrochloride API Consumption Market Share by Country (2020-2031)

Figure 33. U.S. Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 34. Canada Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 35. Europe Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 36. Europe Gemcitabine Hydrochloride API Consumption Market Share by Country (2020-2031)

Figure 37. Germany Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 38. France Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 39. U.K. Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 40. Italy Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 41. Russia Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 42. Asia Pacific Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 43. Asia Pacific Gemcitabine Hydrochloride API Consumption Market Share by Region (2020-2031)

Figure 44. China Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 45. Japan Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 46. South Korea Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 47. China Taiwan Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 48. Southeast Asia Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 49. India Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 50. Latin America, Middle East & Africa Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 51. Latin America, Middle East & Africa Gemcitabine Hydrochloride API Consumption Market Share by Country (2020-2031)

Figure 52. Mexico Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 53. Brazil Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 54. Turkey Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 55. GCC Countries Gemcitabine Hydrochloride API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 56. Global Production Market Share of Gemcitabine Hydrochloride API by Type (2020-2031)

Figure 57. Global Production Value Market Share of Gemcitabine Hydrochloride API by Type (2020-2031)

Figure 58. Global Gemcitabine Hydrochloride API Price (US$/Ton) by Type (2020-2031)

Figure 59. Global Production Market Share of Gemcitabine Hydrochloride API by Application (2020-2031)

Figure 60. Global Production Value Market Share of Gemcitabine Hydrochloride API by Application (2020-2031)

Figure 61. Global Gemcitabine Hydrochloride API Price (US$/Ton) by Application (2020-2031)

Figure 62. Gemcitabine Hydrochloride API Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

Report Code:

QYRE-Othe-4P349

Published:

Mon Feb 05 07:28:02 UTC 2024

Est. Total

$16500.0